News
-
One in three addicts suffer from post-traumatic stress disorder (PTSD). To ensure that addicts reap lasting treatment benefits, it's often necessary to treat them for underlying traumas as well...
-
MaCSBio's director of education Bert Smeets has been interviewed for the Dutch serie: 'Research Loont' (translation: 'Research pays off') about the unraveling of genetic causes of hereditary metabolic disease among children.
-
"A BREXIT? Political, financial and legal aspects"
A forum about the UK Brexit referendum of 23 June 2016. -
Effective 1 May, Jan Cobbenhagen will be the new Chief Executive Officer of the Brightlands Maastricht Health Campus (BL MHC).
-
Effective 1 May, Jan Cobbenhagen will be the new Chief Executive Officer of the Brightlands Maastricht Health Campus (BL MHC).
-
Professor Philippe Lambin of Maastricht UMC+ and the Maastro Clinic has been awarded a prestigious Advanced Grant by the European Research Council (ERC).
-
‘Our excessive individualism is at the root of the unwillingness to solve environmental problems.
-
Researchers at the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University have developed a smarter method for growing human tissues in laboratories. This method cleverly stimulates the natural self-organising capacity of stem cells to form complex tissues.
-
If COPD can be detected at an earlier stage in healthy people, this can improve treatment and may lead to lower direct health care costs. COPD is an insidious disease; you feel nothing until part of your lung function is lost. The disease is predicted to become the third leading cause of death in Europe by 2020.
-
Christophe van Eecke has been awarded one of the five Research Prizes from the Praemium Erasmianum Foundation for his PhD dissertation titled ‘Pandaemonium: Ken Russell’s Artist Biographies as Baroque Performance’.